BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30053805)

  • 1. Cumulative evidence for relationships between multiple variants of HNF1B and the risk of prostate and endometrial cancers.
    Tong Y; Qu Y; Li S; Zhao F; Wang Y; Mu D
    BMC Med Genet; 2018 Jul; 19(1):128. PubMed ID: 30053805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale fine mapping of the HNF1B locus and prostate cancer risk.
    Berndt SI; Sampson J; Yeager M; Jacobs KB; Wang Z; Hutchinson A; Chung C; Orr N; Wacholder S; Chatterjee N; Yu K; Kraft P; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Schumacher FR; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Haiman C; Henderson B; Kolonel L; Le Marchand L; Siddiq A; Riboli E; Travis RC; Kaaks R; Isaacs W; Isaacs S; Wiley KE; Gronberg H; Wiklund F; Stattin P; Xu J; Zheng SL; Sun J; Vatten LJ; Hveem K; Njølstad I; Gerhard DS; Tucker M; Hayes RB; Hoover RN; Fraumeni JF; Hunter DJ; Thomas G; Chanock SJ
    Hum Mol Genet; 2011 Aug; 20(16):3322-9. PubMed ID: 21576123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.
    Stevens VL; Ahn J; Sun J; Jacobs EJ; Moore SC; Patel AV; Berndt SI; Albanes D; Hayes RB
    Prostate; 2010 May; 70(6):601-7. PubMed ID: 19998368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the association between the HNF1B rs4430796 (A>G) polymorphism and risk of prostate cancer based on case-control studies.
    Zhao Y; Liang J; Qi JG; Yang N; Wu G; Lin YL; Cao JY; Wang Q; Wang QC
    Genet Mol Res; 2015 Jul; 14(3):7426-35. PubMed ID: 26214421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association study identifies a common variant associated with risk of endometrial cancer.
    Spurdle AB; Thompson DJ; Ahmed S; Ferguson K; Healey CS; O'Mara T; Walker LC; Montgomery SB; Dermitzakis ET; ; Fahey P; Montgomery GW; Webb PM; Fasching PA; Beckmann MW; Ekici AB; Hein A; Lambrechts D; Coenegrachts L; Vergote I; Amant F; Salvesen HB; Trovik J; Njolstad TS; Helland H; Scott RJ; Ashton K; Proietto T; Otton G; ; Tomlinson I; Gorman M; Howarth K; Hodgson S; Garcia-Closas M; Wentzensen N; Yang H; Chanock S; Hall P; Czene K; Liu J; Li J; Shu XO; Zheng W; Long J; Xiang YB; Shah M; Morrison J; Michailidou K; Pharoah PD; Dunning AM; Easton DF
    Nat Genet; 2011 May; 43(5):451-4. PubMed ID: 21499250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies.
    Elliott KS; Zeggini E; McCarthy MI; Gudmundsson J; Sulem P; Stacey SN; Thorlacius S; Amundadottir L; Grönberg H; Xu J; Gaborieau V; Eeles RA; Neal DE; Donovan JL; Hamdy FC; Muir K; Hwang SJ; Spitz MR; Zanke B; Carvajal-Carmona L; Brown KM; ; Hayward NK; Macgregor S; Tomlinson IP; Lemire M; Amos CI; Murabito JM; Isaacs WB; Easton DF; Brennan P; ; Barkardottir RB; Gudbjartsson DF; Rafnar T; Hunter DJ; Chanock SJ; Stefansson K; Ioannidis JP
    PLoS One; 2010 May; 5(5):e10858. PubMed ID: 20526366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
    Painter JN; O'Mara TA; Batra J; Cheng T; Lose FA; Dennis J; Michailidou K; Tyrer JP; Ahmed S; Ferguson K; Healey CS; Kaufmann S; Hillman KM; Walpole C; Moya L; Pollock P; Jones A; Howarth K; Martin L; Gorman M; Hodgson S; ; ; De Polanco MM; Sans M; Carracedo A; Castellvi-Bel S; Rojas-Martinez A; Santos E; Teixeira MR; Carvajal-Carmona L; Shu XO; Long J; Zheng W; Xiang YB; ; Montgomery GW; Webb PM; Scott RJ; McEvoy M; Attia J; Holliday E; Martin NG; Nyholt DR; Henders AK; Fasching PA; Hein A; Beckmann MW; Renner SP; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Lambrechts D; Coenegrachts L; Schrauwen S; Amant F; Winterhoff B; Dowdy SC; Goode EL; Teoman A; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Ashton K; Proietto T; Otton G; Tzortzatos G; Mints M; Tham E; ; Hall P; Czene K; Liu J; Li J; Hopper JL; Southey MC; ; Ekici AB; Ruebner M; Johnson N; Peto J; Burwinkel B; Marme F; Brenner H; Dieffenbach AK; Meindl A; Brauch H; ; Lindblom A; Depreeuw J; Moisse M; Chang-Claude J; Rudolph A; Couch FJ; Olson JE; Giles GG; Bruinsma F; Cunningham JM; Fridley BL; Børresen-Dale AL; Kristensen VN; Cox A; Swerdlow AJ; Orr N; Bolla MK; Wang Q; Weber RP; Chen Z; Shah M; French JD; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Edwards SL; Thompson DJ; Spurdle AB
    Hum Mol Genet; 2015 Mar; 24(5):1478-92. PubMed ID: 25378557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12.
    Sun J; Zheng SL; Wiklund F; Isaacs SD; Purcell LD; Gao Z; Hsu FC; Kim ST; Liu W; Zhu Y; Stattin P; Adami HO; Wiley KE; Dimitrov L; Sun J; Li T; Turner AR; Adams TS; Adolfsson J; Johansson JE; Lowey J; Trock BJ; Partin AW; Walsh PC; Trent JM; Duggan D; Carpten J; Chang BL; Grönberg H; Isaacs WB; Xu J
    Nat Genet; 2008 Oct; 40(10):1153-5. PubMed ID: 18758462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.
    Ross-Adams H; Ball S; Lawrenson K; Halim S; Russell R; Wells C; Strand SH; Ørntoft TF; Larson M; Armasu S; Massie CE; Asim M; Mortensen MM; Borre M; Woodfine K; Warren AY; Lamb AD; Kay J; Whitaker H; Ramos-Montoya A; Murrell A; Sørensen KD; Fridley BL; Goode EL; Gayther SA; Masters J; Neal DE; Mills IG
    Oncotarget; 2016 Nov; 7(46):74734-74746. PubMed ID: 27732966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.
    Harries LW; Perry JR; McCullagh P; Crundwell M
    BMC Cancer; 2010 Jun; 10():315. PubMed ID: 20569440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HNF1B and endometrial cancer risk: results from the PAGE study.
    Setiawan VW; Haessler J; Schumacher F; Cote ML; Deelman E; Fesinmeyer MD; Henderson BE; Jackson RD; Vöckler JS; Wilkens LR; Yasmeen S; Haiman CA; Peters U; Le Marchand L; Kooperberg C
    PLoS One; 2012; 7(1):e30390. PubMed ID: 22299039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HNF1B polymorphism associated with development of prostate cancer in Korean patients.
    Kim HJ; Bae JS; Lee J; Chang IH; Kim KD; Shin HD; Han JH; Lee SY; Kim W; Myung SC
    Urology; 2011 Oct; 78(4):969.e1-6. PubMed ID: 21982019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HNF1B polymorphism influences the prognosis of endometrial cancer patients: a cohort study.
    Mandato VD; Farnetti E; Torricelli F; Abrate M; Casali B; Ciarlini G; Pirillo D; Gelli MC; Nicoli D; Grassi M; LA Sala GB; Palomba S
    BMC Cancer; 2015 Apr; 15():229. PubMed ID: 25885815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in the association between diabetes mellitus-associated polymorphic locus rs4430796 of the HNF1β gene and prostate cancer: a systematic review and meta-analysis.
    Xiang YZ; Jiang SB; Zhao J; Xiong H; Cui ZL; Li GB; Jin XB
    Genet Mol Res; 2014 Aug; 13(3):6582-92. PubMed ID: 25177939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
    Machiela MJ; Lindström S; Allen NE; Haiman CA; Albanes D; Barricarte A; Berndt SI; Bueno-de-Mesquita HB; Chanock S; Gaziano JM; Gapstur SM; Giovannucci E; Henderson BE; Jacobs EJ; Kolonel LN; Krogh V; Ma J; Stampfer MJ; Stevens VL; Stram DO; Tjønneland A; Travis R; Willett WC; Hunter DJ; Le Marchand L; Kraft P
    Am J Epidemiol; 2012 Dec; 176(12):1121-9. PubMed ID: 23193118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between genetic polymorphisms and endometrial cancer risk: a systematic review.
    Bafligil C; Thompson DJ; Lophatananon A; Smith MJ; Ryan NA; Naqvi A; Evans DG; Crosbie EJ
    J Med Genet; 2020 Sep; 57(9):591-600. PubMed ID: 32066633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
    Chen Y; Yu X; Li T; Yan H; Mo Z
    Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cumulative evidence for relationships between multiple variants in the VTI1A and TCF7L2 genes and cancer incidence.
    Zhang M; Tang M; Fang Y; Cui H; Chen S; Li J; Xiong H; Lu J; Gu D; Zhang B
    Int J Cancer; 2018 Feb; 142(3):498-513. PubMed ID: 28949031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJ.
    Menezes RDS; Dornas MC; Campos CFF; Rodeiro DB; Carrerette FB; Oliveira RV; de Souza BA; Alves de Souza Carvalho G; Brito IAA; Silva DA; Damião R; Porto LC
    Prostate; 2024 Feb; 84(2):166-176. PubMed ID: 37839045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study of endometrial cancer in E2C2.
    De Vivo I; Prescott J; Setiawan VW; Olson SH; Wentzensen N; ; Attia J; Black A; Brinton L; Chen C; Chen C; Cook LS; Crous-Bou M; Doherty J; Dunning AM; Easton DF; Friedenreich CM; Garcia-Closas M; Gaudet MM; Haiman C; Hankinson SE; Hartge P; Henderson BE; Holliday E; Horn-Ross PL; Hunter DJ; Le Marchand L; Liang X; Lissowska J; Long J; Lu L; Magliocco AM; McEvoy M; O'Mara TA; Orlow I; Painter JN; Pooler L; Rastogi R; Rebbeck TR; Risch H; Sacerdote C; Schumacher F; Scott RJ; Sheng X; Shu XO; Spurdle AB; Thompson D; Vanden Berg D; Weiss NS; Xia L; Xiang YB; Yang HP; Yu H; Zheng W; Chanock S; Kraft P
    Hum Genet; 2014 Feb; 133(2):211-24. PubMed ID: 24096698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.